Divi's Laboratories Ltd. (DIVISLAB): Divi's Laboratories Share Price hits fresh 52-week high; stock gains 1.04%

Published: 28 August 2026 at 10:06 AM IST

Divi's Laboratories Share Price opened this session in focus after the stock moved to Rs 9,144, up 1.04% from the previous close of Rs 9,050. The day’s fresh 52-week high was Rs 9,189, while the company’s market capitalisation stood at Rs 2,39,321.25 crore. This Divi's Laboratories Share Price update is relevant because the price action confirms a new yearly high, but the supplied data does not establish a company-specific catalyst for the move. Univest is tracking the stock around this event with its latest stock news coverage and market data reference points.

The latest Divi's Laboratories Share Price Today reading places the stock near its intraday high, with the session low at Rs 9,080.05 and the open at Rs 9,149.60. The move keeps Divi's Laboratories Stock News in the spotlight for readers following Divi's Laboratories Share Price Live, especially because the event is a fresh 52-week high rather than a record high. For investors scanning Divi's Laboratories Share News, the key verified point is straightforward: the stock has set a new one-year high on the day, and Univest is presenting the price, valuation and sector context without adding an unsupported explanation.

Divi's Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 9,144
Previous Close	Rs 9,050
Today's Move	+Rs 94 (+1.04%)
Open	Rs 9,149.6
High	Rs 9,189
Low	Rs 9,080.05
Turnover	Rs 2.9 crore
Market Capitalisation	Rs 2,39,321.25 crore

Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 9,144 versus the previous close of Rs 9,050, a rise of 1.04%. The stock opened at Rs 9,149.6, reached a high of Rs 9,189 and touched a low of Rs 9,080.05.

The price action shows Divi's Laboratories Share Price moving from Rs 9,050 to Rs 9,144, a gain of Rs 94 or 1.04%. The session opened at Rs 9,149.60, moved between Rs 9,080.05 and Rs 9,189, and finished with the day’s peak matching the fresh 52-week high. That means the stock ended close to the highest traded level of the day, with a breakout of 0.00% over the previous 52-week high because the supplied earlier peak was also Rs 9,189. Turnover stood at Rs 2.9 crore, giving a factual scale for the session’s traded value. For readers checking Divi's Laboratories Share Price Today, the event is a clean yearly high update and not a broader market narrative. Univest treats the move as an event-led price update rather than a claim about why the stock rose.

What exactly happened today is clear from the numbers: the stock advanced, set a fresh 52-week high, and held above the previous close through the session. Divi's Laboratories Share Price therefore enters the day’s stock news flow with a verified price milestone, while the data remains neutral on any company-specific trigger.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,39,321.25 crore
P/E Ratio	82.14x
P/B Ratio	13.6x
ROE	16.19%
ROCE	21.51%
EPS	Rs 110.18
Book Value Per Share	Rs 665.36
Dividend Yield	0.33%

Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 82.14x, P/B 13.6x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.

Divi's Laboratories Ltd. has a market capitalisation of Rs 239321.25 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.14x, P/B at 13.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.33%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.15x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	82.14x
Benchmark Median P/E	31.15x
Benchmark Average P/E	47.85x
Benchmark P/E Range	3.36x to 397.25x
Company P/B Ratio	13.6x
Benchmark Median P/B	2.64x
Company ROE	16.19%
Benchmark Median ROE	11.81%
Company ROCE	21.51%
Benchmark Median ROCE	13.68%
Company Market Capitalisation	Rs 2,39,321.25 crore
Benchmark Median Market Cap	Rs 633.24 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 82.14x, which is above the benchmark median of 31.15x, a difference of +163.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.81%, a difference of +37.09%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.68%, a difference of +57.24%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,85,923.81	87.64	21.3	26.76	19.27
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,56,113.58	37.7	5.27	14.85	19.11
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,14,508.45	26.28	4.4	19.69	21.39
Cipla Ltd.	CIPLA	1,13,778.04	34.03	3.26	11.83	16
Laurus Labs Ltd.	LAURUSLABS	1,02,010.95	94.88	18.4	18.31	18.2

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 82.14x compared with the displayed peer median of 37.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,39,321.25 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories

• Divi's Laboratories Share Price touched a fresh 52-week high of Rs 9,189 and closed at Rs 9,144.
• The stock gained Rs 94, or 1.04%, from the previous close of Rs 9,050.
• Market capitalisation stood at Rs 2,39,321.25 crore.
• P/E was 82.14, P/B was 13.6, EPS was Rs 110.18 and book value per share was Rs 665.36.
• ROE was 16.19%, ROCE was 21.51% and dividend yield was 0.33%.

About Divi's Laboratories

Divi's Laboratories Ltd. (DIVISLAB) belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile data identifies the stock on NSE and BSE, and the financial record set covers earnings, revenue, asset growth and equity metrics. Univest uses this Company Overview to keep Divi's Laboratories Share Price analysis tied to verified data, rather than broad industry assumptions.

The company financials supplied in the data show revenue at Rs 24,100 crore in Jun 2025, Rs 27,150 crore in Sep 2025, Rs 26,040 crore in Dec 2025, Rs 28,310 crore in Mar 2026 and Rs 30,800 crore in Jun 2026. Net profit moved from Rs 5,450 crore in Jun 2025 to Rs 9,020 crore in Jun 2026. EPS values across the supplied period also show a progression from Rs 111.53 in 2022 to Rs 96.91 in 2026, while book value per share for 2026 stands at Rs 665.36. These figures add factual depth to Divi's Laboratories Fundamental Analysis and help explain why the stock remains present in Stock Market Today discussions.

Track Divi's Laboratories Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Divi's Laboratories Share Price on Univest for live share price updates, market capitalisation, 52-week levels, shareholding pattern, valuation ratios, company financials and market insights. Univest also keeps Divi's Laboratories Share Price Today and Divi's Laboratories Stock News organised in one place for quick reference.

For those scanning Divi's Laboratories Share Price Live, Univest offers a single view of the stock's latest news, fundamental ratios, sector comparison and performance context. That makes it easier to follow Divi's Laboratories News Today without searching across multiple sources.

Frequently Asked Questions

What is Divi's Laboratories Share Price today?

Ans. Divi's Laboratories Share Price today is Rs 9,144. It rose Rs 94, or 1.04%, from the previous close of Rs 9,050 and also touched a fresh 52-week high of Rs 9,189 during the session.

Did Divi's Laboratories hit a fresh 52-week high?

Ans. Yes. Divi's Laboratories Share Price touched a fresh 52-week high of Rs 9,189 in the session. The same level was also the day’s high, so the event confirms a new yearly high in the supplied data.

What is the market capitalisation of Divi's Laboratories?

Ans. Divi's Laboratories has a market capitalisation of Rs 2,39,321.25 crore. That places the stock well above the same-industry benchmark median and average shown in the supplied healthcare peer set. The company operates in the Healthcare sector.

How did Divi's Laboratories perform from the previous close?

Ans. The stock gained Rs 94 from the previous close of Rs 9,050 to Rs 9,144. The day’s move equals 1.04%, which is the verified percentage change in the supplied market data.

What are Divi's Laboratories valuation metrics?

Ans. Divi's Laboratories Share Price is supported by a P/E ratio of 82.14 and a P/B ratio of 13.6. EPS is Rs 110.18 and book value per share is Rs 665.36, giving a clear valuation context.

How do Divi's Laboratories ROE and ROCE compare in the data?

Ans. ROE is 16.19% and ROCE is 21.51%. Both are above the same-industry benchmark median in the supplied sector snapshot, which helps frame Divi's Laboratories Share Price against its peer set.

What is the dividend yield of Divi's Laboratories?

Ans. The supplied dividend yield for Divi's Laboratories is 0.33%. This is historical and current data, not a future payout promise, and it sits alongside the stock’s valuation and earnings metrics.

How do revenue and profit look in the latest supplied figures?

Ans. Revenue rose to Rs 30,800 crore in Jun 2026 from Rs 24,100 crore in Jun 2025. Net profit also increased to Rs 9,020 crore in Jun 2026 from Rs 5,450 crore in Jun 2025.

Which sector and industry does Divi's Laboratories belong to?

Ans. Divi's Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Those classifications frame the benchmark comparison used in this Divi's Laboratories Share Price analysis. The stock belongs to the Healthcare sector.

How does Divi's Laboratories compare with selected peers?

Ans. In the supplied peer set, Divi's Laboratories has a larger market cap than Zydus Lifesciences, Cipla and Laurus Labs, but smaller than Torrent Pharmaceuticals and Sun Pharmaceutical Industries. Its P/E also sits above several peers.